DEBITO Cambiamento Data
Astellas Pharma JPY 589.87B 23.92B 2026-06
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Cara Therapeutics USD 0 0 2025-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Heron Therapeutics USD 149.65M 157K 2024-09
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
J&J USD 49.04B 5.95B 2026-06
Ligand Pharmaceuticals USD 1.13B 679.48M 2026-06
Nektar Therapeutics USD 0 0 2022-06
Novo Nordisk DKK 118.72B 61.75B 2025-03
Omeros USD 442.16M 199K 2023-09
Pacira USD 293.59M 69.53M 2026-09
Perrigo USD 3.29B 337.7M 2026-06
Pfizer USD 62.67B 523M 2026-09
Supernus Pharmaceuticals USD 40.17M 733K 2026-06
Teva Pharmaceutical Industries USD 16.98B 110M 2026-09
Xeris Pharmaceuticals USD 289.44M 30.89M 2026-06
Zoetis USD 9.24B 0 2026-06